Lawrence Erik Kurzius
CIK 1352090 · Chairman & CEO · last filed 2026-10-09
Lawrence Erik Kurzius is a Chairman & CEO who has filed 170 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for LW, was dated Oct 9, 2026. Across all open-market trades the lifetime net is −$85.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $22.1M across reported positions. 45 SEC filings were submitted jointly with Elanco Animal Health Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MKC.V price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HUNT VALLEY, MD 21031
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LW | Director | 11,054 | $56.97 | $629.7K | $0 | 3 | 2026-10-09 |
| COO | Director | 31,099 | $64.06 | $1.99M | $1.39M | 8 | 2026-09-17 |
| ELAN | Director | 188,647 | $27.12 | $5.12M | $1.60M | 19 | 2026-08-21 |
| MKC.V | 10%+ Owner | 296,992 | $48.25 | $14.33M | -$88.73M | 113 | 2026-08-12 |
| Elanco Animal Health Inc (ELAT) Delisted | Director | 52,916 | $21.32 | $1.13M | $0 | 24 | 2023-01-03 |
Recent Filings
170 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-09 | LW | Grant (A) | +5,458 | $0 | EDGAR |
| 2026-09-17 | COO | Buy (P) | +10,000 | $549.3K | EDGAR |
| 2026-09-15 | COO | Buy (P) | +10,000 | $539.1K | EDGAR |
| 2026-08-21 | ELAN | Buy (P) | +40,000 | $935.9K | EDGAR |
| 2026-08-12 | MKC.V | Mixed | — | -$752.7K | EDGAR |
| 2026-05-26 | ELAN | Grant (A) | +16,874 | $0 | EDGAR |
| 2026-04-06 | COO | Mixed | +3,322 | $0 | EDGAR |
| 2026-02-13 | MKC.V | Mixed | — | -$1.13M | EDGAR |
| 2026-01-21 | MKC.V | Grant (A) | +50,230 | $0 | EDGAR |
| 2026-01-14 | MKC.V | Mixed | — | -$873.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.